4/18/2023 6:00 PM - 4/18/2023 7:30 PM
Add to Calendar
Manali Bhave, MD
Assistant Professor, Hematology & Medical Oncology
School of Medicine
Kevin Kalinsky, MD, MS
Associate Professor, Hematology & Medical Oncology
School of Medicine
Suchita Pakkala, MD
Assistant Professor, Hematology & Medical Oncology
School of Medicine
Stephanie Graff, MD
Director of Breast Oncology
Lifespan Cancer Institute
Julia McGuiness, MD
Assistant Professor, Department of Medicine
Columbia University Irving Medical Center
Join this team of experts for discussions that will offer unique perspectives on emerging topics in cancer management.
Discussion Topics:
- CDK 4/6 Inhibitors for Metastatic HR+ Breast Can-cer: Are They the Same or Different?
- The Promise of Oral SERDS for HR+ Breast Cancer
- Evolving Landscape of ADCs for HR+ and HER2 Low Breast Cancer
- Novel Therapeutics for HR+ HER2- Metastatic Breast Cancer (AKT Inhibitors, ARV-471, CDK7 Inhibitors)
Program Chair:
Manali Bhave, MD
Winship Cancer Institute of Emory University
OncLive® Institutional Perspectives in Cancer (IPC) are short meetings designed to educate oncologists and HCPs on the clinical benefits associated with the new science driving updates in cancer management. Our renowned faculty focus on the most relevant cancer topics to ultimately improve patient care.
Registration for this virtual event is complimentary. For more information and to register, visit the OncLive website.